In this webinar recording, we'll give you an overview of the end-to-end clinical trial process, highlighting common challenges, with tools and techniques to overcome these and reach submission quicker.
At CDISC International Interchange 2014, Formedix CEO Mark Wheeldon delivered this short "CDISC: Standards from the Start" presentation before participating in a panel discussion.
Formedix CEO Mark Wheeldon delivered this in-depth Define-XML presentation at PhUSE 2014 in London. You'll learn about Define-XML's varied uses beyond dataset description.
This infographic illustrates six of the most common challenges that CROs experience in the battle to win sponsor business.
This presentation discusses real life-experiences of using CDISC Database Standards (Operational Data Model) to drive efficiencies in study setup and study build.
This white paper shows, at-a-glance, the new features and improvements in the latest version of this CDISC standard and its day-to-day use.
Formedix CEO Mark Wheeldon's presentation from the 2013 Bay Area User Group, which looks at practical uses of Define-XML in the end-to-end clinical trial process.
Presentation from Formedix-hosted Bay Area Executive Breakfast, discussing standards to enable efficiencies throughout the end-to-end clinical trial process.
This presentation from CDISC Europe Interchange 2013 explains how an ‘iTunes-style’ metadata repository can be established using CDISC standardized content, in a CDISC vendor-neutral model.
CEO Mark Wheeldon's presentation from DIA EuroMeeting, March 2012, on how CDISC models can be adopted throughout the end-to-end clinical trial process.